These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15325000)

  • 1. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
    Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
    Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
    Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
    J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T
    J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
    Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
    J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.
    Salama ME; Parham DM; Perkins SL; Bahler DW; Ellison DA
    Pediatr Dev Pathol; 2008; 11(6):443-9. PubMed ID: 18473605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
    Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
    Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
    Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
    J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
    Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
    J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.
    Kawaguchi H; Miyashita T; Herbst H; Niedobitek G; Asada M; Tsuchida M; Hanada R; Kinoshita A; Sakurai M; Kobayashi N
    J Clin Invest; 1993 Sep; 92(3):1444-50. PubMed ID: 8397226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
    Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.